Studies of wine tasters and patients with self-induced vomiting have revealed that 30-50% of individuals at high risk do not develop erosive lesions. The aim was to investigate this apparent individual susceptibility to enamel erosion. Two enamel specimens were made from each of 3 premolars from 8 persons (donors). Six acrylic mouth appliances were worn by 6 volunteers (carriers). One specimen from each donor was mounted on each appliance. The carriers wore the appliances for 9 days. The appliances were immersed in 0.01 M HCl for 3 min twice per day to imitate a vomiting/reflux situation. The enamel specimens were analysed by a white-light interferometer to measure enamel loss (in micrometres). The enamel loss varied significantly both between the donor teeth (p = 0.009) and the carriers (p = 0.004). The lesion in the specimen with the largest amount of enamel loss was 4 times as deep as in the specimen with the lowest. In 1 carrier, all specimens displayed enamel loss above the mean, including the specimen from the donor with the most resistant enamel. The variation in susceptibility to erosion among individuals appears to be influenced both by the sustainability of the enamel and by factors in the oral environment. This could explain the variation in prevalence and severity of dental erosions among patients exposed to similar acidic challenges. The results suggest that for certain individuals, only minimal acidic challenges may be sufficient to cause damage to the teeth, while others may never develop dental erosions despite extensive exposure to acid.

Keywords:
Dental enamel, Disease susceptibility, Humans, Oral health, Preventive dentistry, Tooth demineralization, Tooth erosion
1.
Axelsson P: Diagnosis and Risk Prediction of Dental Caries. Hanover Park, Quintessence Publishing, 2000.
2.
Bruvo M, Moe D, Kirkeby S, Vorum H, Bardow A: Individual variations in protective effects of experimentally formed salivary pellicles. Caries Res 2009;43:163-170.
3.
Dawes C: Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 1987;66:648-653.
4.
Deeley K, Letra A, Rose EK, Brandon CA, Resick JM, Marazita ML, Vieira AR: Possible association of amelogenin to high caries experience in a Guatemalan-Mayan population. Caries Res 2008;42:8-13.
5.
Diaz-Arnold AM, Marek CA: The impact of saliva on patient care: a literature review. J Prosthet Dent 2002;88:337-343.
6.
Duckworth RM, Morgan SN, Murray AM: Fluoride in saliva and plaque following use of fluoride-containing mouthwashes. J Dent Res 1987;66:1730-1734.
7.
Ekstrand J: Fluoride concentrations in saliva after single oral doses and their relation to plasma fluoride. Scand J Dent Res 1977;85:16-17.
8.
Fejerskov Ole KE: Dental Caries: The Disease and Its Clinical Management, ed 2. Copenhagen, Blackwell Munksgaard, 2008.
9.
Ganss C, Schlueter N, Klimek J: Retention of KOH-soluble fluoride on enamel and dentine under erosive conditions - a comparison of in vitro and in situ results. Arch Oral Biol 2007;52:9-14.
10.
Hannig M, Hannig C: The pellicle and erosion. Monogr Oral Sci 2014;25:206-214.
11.
Hara AT, Ando M, Gonzalez-Cabezas C, Cury JA, Serra MC, Zero DT: Protective effect of the dental pellicle against erosive challenges in situ. J Dent Res 2006;85:612-616.
12.
Hara AT, Zero DT: The potential of saliva in protecting against dental erosion. Monogr Oral Sci 2014;25:197-205.
13.
Holme B, Hove LH, Tveit AB: Using white light interferometry to measure etching of dental enamel. Meas Sci Technol 2005;38:137-147.
14.
Hove LH, Holme B, Stenhagen KR, Tveit AB: Protective effect of TiF4 solutions with different concentrations and pH on development of erosion-like lesions. Caries Res 2011;45:64-68.
15.
Hove LH, Holme B, Young A, Tveit AB: The protective effect of TiF4, SnF2 and NaF against erosion-like lesions in situ. Caries Res 2008;42:68-72.
16.
Hove LH, Stenhagen KR, Holme B, Tveit AB: The protective effect of SnF2 containing toothpastes and solution on enamel surfaces subjected to erosion and abrasion in situ. Eur Arch Paediatr Dent 2014;15:237-243.
17.
Huysmans MC, Young A, Ganss C: The role of fluoride in erosion therapy. Monogr Oral Sci 2014;25:230-243.
18.
Hystad Hove L, Refsholt Stenhagen K, Mulic A, Holme B, Tveit AB: May caries-preventive fluoride regimes have an effect on dental erosive wear? An in situ study. Acta Odontol Scand 2015;73:114-120.
19.
Jaeggi T, Lussi A: Prevalence, incidence and distribution of erosion. Monogr Oral Sci 2014;25:55-73.
20.
Jarvinen VK, Rytomaa, II, Heinonen OP: Risk factors in dental erosion. J Dent Res 1991;70:942-947.
21.
Lambrou D, Larsen MJ, Fejerskov O, Tachos B: The effect of fluoride in saliva on remineralization of dental enamel in humans. Caries Res 1981;15:341-345.
22.
Lussi A: Erosive tooth wear - a multifactorial condition of growing concern and increasing knowledge. Monogr Oral Sci 2006;20:1-8.
23.
Lussi A, Jaeggi T: Erosion - diagnosis and risk factors. Clin Oral Investig 2008;12(suppl 1):S5-S13.
24.
Magalhaes AC, Wiegand A, Rios D, Buzalaf MA, Lussi A: Fluoride in dental erosion. Monogr Oral Sci 2011;22:158-170.
25.
Milosevic A, Slade PD: The orodental status of anorexics and bulimics. Br Dent J 1989;167:66-70.
26.
Moazzez RV, Austin RS, Rojas-Serrano M, Carpenter G, Cotroneo E, Proctor G, Zaidel L, Bartlett DW: Comparison of the possible protective effect of the salivary pellicle of individuals with and without erosion. Caries Res 2014;48:57-62.
27.
Mulic A, Tveit AB, Hove LH, Skaare AB: Dental erosive wear among Norwegian wine tasters. Acta Odontol Scand 2011;69:21-26.
28.
Rytomaa I, Jarvinen V, Kanerva R, Heinonen OP: Bulimia and tooth erosion. Acta Odontol Scand 1998;56:36-40.
29.
Slayton RL, Cooper ME, Marazita ML: Tuftelin, mutans streptococci, and dental caries susceptibility. J Dent Res 2005;84:711-714.
30.
Sovik JB, Vieira AR, Tveit AB, Mulic A: Enamel formation genes associated with dental erosive wear. Caries Res 2015;49:236-242.
31.
Stenhagen KR, Hove LH, Holme B, Taxt-Lamolle S, Tveit AB: Comparing different methods to assess erosive lesion depths and progression in vitro. Caries Res 2010;44:555-561.
32.
Stenhagen KR, Hove LH, Holme B, Tveit AB: The effect of daily fluoride mouth rinsing on enamel erosive/abrasive wear in situ. Caries Res 2013;47:2-8.
33.
Tenovuo J: Salivary parameters of relevance for assessing caries activity in individuals and populations. Community Dent Oral Epidemiol 1997;25:82-86.
34.
Touyz SW, Liew VP, Tseng P, Frisken K, Williams H, Beumont PJ: Oral and dental complications in dieting disorders. Int J Eat Disord 1993;14:341-347.
35.
Uhlen MM, Tveit AB, Stenhagen KR, Mulic A: Self-induced vomiting and dental erosion - a clinical study. BMC Oral Health 2014;14:92.
36.
Vieira AR, Modesto A, Marazita ML: Caries: review of human genetics research. Caries Res 2014;48:491-506.
37.
Wetton S, Hughes J, Newcombe RG, Addy M: The effect of saliva derived from different individuals on the erosion of enamel and dentine. A study in vitro. Caries Res 2007;41:423-426.
38.
Zwier N, Huysmans MC, Jager DH, Ruben J, Bronkhorst EM, Truin GJ: Saliva parameters and erosive wear in adolescents. Caries Res 2013;47:548-552.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.